<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">medalphabet-836</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Эффективные подходы к нелекарственной терапии мигрени: роль триггеров и поведенческой терапии</article-title><trans-title-group xml:lang="en"><trans-title>Role of triggers and behavioral therapy in effective approaches to non-drug therapiesfor migraines</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергеев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergeev</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет имени И. М. Сеченова (Сеченовский университет)» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Moscow State Medical University n.a. I. M. Sechenov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>01</day><month>09</month><year>2018</year></pub-date><volume>3</volume><issue>27</issue><issue-title>Неврология и психиатрия</issue-title><fpage>21</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сергеев А.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Сергеев А.В.</copyright-holder><copyright-holder xml:lang="en">Sergeev A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/836">https://www.med-alphabet.com/jour/article/view/836</self-uri><abstract><p>Мигрень является одним из наиболее распространенных неврологических заболеваний. Около 12 % населения периодически испытывают приступы мигрени. При этом около 50 % пациентов с мигренью не удовлетворены результатами проводимой терапии. 40 % пациентов не возвращаются на повторный визит к доктору, и только 25 % соблюдают лечение в течение года. Это подчеркивает высокую важность формирования доверительного диалога между пациентом и доктором, анализа представлений пациента о заболевании, стратегии и ожиданий от терапии. Использование немедикаментозной терапии, выявление и контроль индивидуальных триггеров мигрени имеют высокую эффективность как самостоятельно, так и в сочетании с профилактической фармакотерапией.</p></abstract><trans-abstract xml:lang="en"><p>Migraine is one of the most common neurological diseases. About 12 % of the population periodically experience migraine attacks. in this case about 50 % of patients with migraine are not satisfied with the results of the therapy. 40 % of patients do not return for a second visit to the doctor, and only 25 % adhere to the treatment during the year. This highlights the importance of creating a trustful dialogue between the patient and the doctor, analyzing the patient s views on the disease, strategies and expectations from therapy. The use of non-drug therapy, detection and monitoring of individual triggers of migraine are highly effective both independently and in combination with preventive pharmacotherapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>мигрень</kwd><kwd>триггеры</kwd><kwd>нелекарственная терапия</kwd><kwd>лечение приступа</kwd><kwd>суматриптан</kwd></kwd-group><kwd-group xml:lang="en"><kwd>migraine</kwd><kwd>triggers</kwd><kwd>non-drug therapy</kwd><kwd>treatment of attack</kwd><kwd>sumatriptan</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 Dec; 6 (6): 429-40.</mixed-citation><mixed-citation xml:lang="en">Leonardi M, Steiner TJ, Scher AT, Lipton RB. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF). J Headache Pain. 2005 Dec; 6 (6): 429-40.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Осипова В. В., Филатова Е. Г., Артеменко А. Р., Лебедева Е. Р., Азимова Ю. Э., Латышева Н. В., Сергеев А. В., Амелин А. В., Корешкина М. И., Скоробогатых К. В., Екушева Е. В., Наприенко М. В., Исагулян Э. Д., Рачин А. П., Данилов Ал.Б.,Курушина О. В., Парфенов В. А., Табеева Г. Р., Гехт А. Б., Яхно Н. Н. Диагностика и лечение мигрени: рекомендации российских экспертов. Журнал неврологии и психиатрии им. С. С. Корсакова. Спецвыпуски. 2017; 117 (1): 28-42.</mixed-citation><mixed-citation xml:lang="en">Осипова В. В., Филатова Е. Г., Артеменко А. Р., Лебедева Е. Р., Азимова Ю. Э., Латышева Н. В., Сергеев А. В., Амелин А. В., Корешкина М. И., Скоробогатых К. В., Екушева Е. В., Наприенко М. В., Исагулян Э. Д., Рачин А. П., Данилов Ал.Б.,Курушина О. В., Парфенов В. А., Табеева Г. Р., Гехт А. Б., Яхно Н. Н. Диагностика и лечение мигрени: рекомендации российских экспертов. Журнал неврологии и психиатрии им. С. С. Корсакова. Спецвыпуски. 2017; 117 (1): 28-42.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Minen M, Shome A, Halpern A, Tishler L, Brennan KC, Loder E, Lipton R, Silbersweig D. A migraine management training program for primary care providers: An overview of a survey and pilot study findings, lessons learned, and considerations for further research. Headache. 2016 Apr 56 (4): 725-40.</mixed-citation><mixed-citation xml:lang="en">Minen M, Shome A, Halpern A, Tishler L, Brennan KC, Loder E, Lipton R, Silbersweig D. A migraine management training program for primary care providers: An overview of a survey and pilot study findings, lessons learned, and considerations for further research. Headache. 2016 Apr 56 (4): 725-40.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sàndor PS. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009 Sep; 16 (9): 968-81.</mixed-citation><mixed-citation xml:lang="en">Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sàndor PS. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009 Sep; 16 (9): 968-81.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sun-Edelstein C, Mauskop A. Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache. 2011 Mar; 51 (3): 469-483.</mixed-citation><mixed-citation xml:lang="en">Sun-Edelstein C, Mauskop A. Alternative headache treatments: nutraceuticals, behavioral and physical treatments. Headache. 2011 Mar; 51 (3): 469-483.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Evans RW, Linde M. Expert opinion: adherence to prophylactic migraine medication. Headache. 2009 Jul; 49 (7): 1054-8.</mixed-citation><mixed-citation xml:lang="en">Evans RW, Linde M. Expert opinion: adherence to prophylactic migraine medication. Headache. 2009 Jul; 49 (7): 1054-8.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Сергеев А. В. Доказательная терапия приступа мигрени. Consilium Medicum. Неврология и Ревматология (Прил.). 2015; 1:34-37.</mixed-citation><mixed-citation xml:lang="en">Сергеев А. В. Доказательная терапия приступа мигрени. Consilium Medicum. Неврология и Ревматология (Прил.). 2015; 1:34-37.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Miller V, Palermao T, Powers S, et al. Migraine headaches and sleep disturbances in children. Headache 2003; 43: 362-8.</mixed-citation><mixed-citation xml:lang="en">Miller V, Palermao T, Powers S, et al. Migraine headaches and sleep disturbances in children. Headache 2003; 43: 362-8.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gori S., Morelli N., Maestri M. et al. Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. J Headache Pain 2005; 6: 258-260.</mixed-citation><mixed-citation xml:lang="en">Gori S., Morelli N., Maestri M. et al. Sleep quality, chronotypes and preferential timing of attacks in migraine without aura. J Headache Pain 2005; 6: 258-260.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yalinay Dikmen P, Yavuz BG, Aydinlar E. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol Belg. 2015 Jun; 115 (2): 117-22.</mixed-citation><mixed-citation xml:lang="en">Yalinay Dikmen P, Yavuz BG, Aydinlar E. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol Belg. 2015 Jun; 115 (2): 117-22.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Табеева Г. Р., Сергеев А. В., Громова С. В. Новые аспекты нейробиологии мигрени: роль гипоталамо-пинеальной системы. Журн неврол и психиат 2011 N8 (1). С. 79-85.</mixed-citation><mixed-citation xml:lang="en">Табеева Г. Р., Сергеев А. В., Громова С. В. Новые аспекты нейробиологии мигрени: роль гипоталамо-пинеальной системы. Журн неврол и психиат 2011 N8 (1). С. 79-85.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Koseoglu E, Akboyraz A, Soyuer A, Ersoy AO. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia 2003; 23 (10): 972-6.</mixed-citation><mixed-citation xml:lang="en">Koseoglu E, Akboyraz A, Soyuer A, Ersoy AO. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia 2003; 23 (10): 972-6.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Millichap J, Yee M. The diet factor in pediatric and adolescent migraine. Pediatric Neurol 2003; 28: 9-15.</mixed-citation><mixed-citation xml:lang="en">Millichap J, Yee M. The diet factor in pediatric and adolescent migraine. Pediatric Neurol 2003; 28: 9-15.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012 Jun; 52 (6): 930-45.</mixed-citation><mixed-citation xml:lang="en">Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012 Jun; 52 (6): 930-45.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gibb C, Davies P, Glover V, et al. Chocolate is a migraine provoking agent. Cephalalgia 1991; 11: 93-5.</mixed-citation><mixed-citation xml:lang="en">Gibb C, Davies P, Glover V, et al. Chocolate is a migraine provoking agent. Cephalalgia 1991; 11: 93-5.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Finocchi C, Sivori G. Food as trigger and aggravating factor of migraine. Neurol Sci. 2012 May; 33 Suppl 1: S 77-80.</mixed-citation><mixed-citation xml:lang="en">Finocchi C, Sivori G. Food as trigger and aggravating factor of migraine. Neurol Sci. 2012 May; 33 Suppl 1: S 77-80.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shapiro RE. Caffeine and headaches. Neurol Sci. 2007 May; 28 Suppl 2: S 179-83.</mixed-citation><mixed-citation xml:lang="en">Shapiro RE. Caffeine and headaches. Neurol Sci. 2007 May; 28 Suppl 2: S 179-83.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pascual J, Oterino A (2010) IgG-mediated allergy: a new mechanism for migraine attacks? Cephalalgia 30: 777-778.</mixed-citation><mixed-citation xml:lang="en">Pascual J, Oterino A (2010) IgG-mediated allergy: a new mechanism for migraine attacks? Cephalalgia 30: 777-778.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Cavestro C, Rosatello A, Micca G, Ravotto M, Marino MP, Asteggiano G et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache. 2007 47: 1436-1442.</mixed-citation><mixed-citation xml:lang="en">Cavestro C, Rosatello A, Micca G, Ravotto M, Marino MP, Asteggiano G et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache. 2007 47: 1436-1442.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Headache. 2016 Oct; 56 (9): 1543-1552.</mixed-citation><mixed-citation xml:lang="en">Headache. 2016 Oct; 56 (9): 1543-1552.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Krymchantowski AV, da Cunha Jevoux C. Wine and headache. Headache. 2014 Jun; 54 (6): 967-75.</mixed-citation><mixed-citation xml:lang="en">Krymchantowski AV, da Cunha Jevoux C. Wine and headache. Headache. 2014 Jun; 54 (6): 967-75.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lassen LH, Christiansen I, Iversen HK, Jansen-Olesen I, Olesen J. (2003) The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia 23: 877-886</mixed-citation><mixed-citation xml:lang="en">Lassen LH, Christiansen I, Iversen HK, Jansen-Olesen I, Olesen J. (2003) The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia 23: 877-886</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rauschel V, Straube A, Süß F, Ruscheweyh R. Responsiveness of the autonomic nervous system during paced breathing and mental stress in migraine patients. J Headache Pain. 2015; 16: 82.</mixed-citation><mixed-citation xml:lang="en">Rauschel V, Straube A, Süß F, Ruscheweyh R. Responsiveness of the autonomic nervous system during paced breathing and mental stress in migraine patients. J Headache Pain. 2015; 16: 82.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Goadsby PJ. Stress and migraine: something expected, something unexpected. Neurology. 2014 Apr22; 82 (16): 1388-9.</mixed-citation><mixed-citation xml:lang="en">Goadsby PJ. Stress and migraine: something expected, something unexpected. Neurology. 2014 Apr22; 82 (16): 1388-9.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein MT., Hockaday JM., Hockaday TDR. Migraine and reproductive hormones throughout the menstrual cycle. Lancet. 1975; 1: 543-548.</mixed-citation><mixed-citation xml:lang="en">Epstein MT., Hockaday JM., Hockaday TDR. Migraine and reproductive hormones throughout the menstrual cycle. Lancet. 1975; 1: 543-548.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Табеева Г. Р. Менструальная мигрень. РМЖ № 42008. С. 195-200.</mixed-citation><mixed-citation xml:lang="en">Табеева Г. Р. Менструальная мигрень. РМЖ № 42008. С. 195-200.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart WF., Lipton RB., Chee E., Sawyer J., Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000; 55: 1517-1523.</mixed-citation><mixed-citation xml:lang="en">Stewart WF., Lipton RB., Chee E., Sawyer J., Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000; 55: 1517-1523.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Nestoriuc Y, Martin A. Efficacy of biofeedback for migraine: A meta-analysis. Pain. 2007; 128: 111-127.</mixed-citation><mixed-citation xml:lang="en">Nestoriuc Y, Martin A. Efficacy of biofeedback for migraine: A meta-analysis. Pain. 2007; 128: 111-127.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: Behavioral and physical treatments. US Headache Consortium 2000. Available at: http://www.aan.com/professionals/prac-tice/pdfs/gl0089.pdf (accessed July 16,2010).</mixed-citation><mixed-citation xml:lang="en">Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: Behavioral and physical treatments. US Headache Consortium 2000. Available at: http://www.aan.com/professionals/prac-tice/pdfs/gl0089.pdf (accessed July 16,2010).</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA 2000; 284:2599.</mixed-citation><mixed-citation xml:lang="en">Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA 2000; 284:2599.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Pringsheim T, Becker WJ. Triptans for symptomatic treatment of migraine headache. BMJ 2014; 348: g2285.</mixed-citation><mixed-citation xml:lang="en">Pringsheim T, Becker WJ. Triptans for symptomatic treatment of migraine headache. BMJ 2014; 348: g2285.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
